Toxoplasma gondii:: Protection against colonization of the brain and muscles in a rat model

被引:9
|
作者
Freyre, A. [1 ]
Falcon, J. [1 ]
Mendez, J. [2 ]
Gonzalez, M. [2 ]
机构
[1] Univ Republica, Lab Toxoplasmosis, Dept Parasitol, Fac Vet, Montevideo 11600, Uruguay
[2] Fac Quim Montevideo, Parasitol Lab, Montevideo, Uruguay
关键词
Toxoplasma gondii; brain and muscles; protection; rat model;
D O I
10.1016/j.exppara.2008.02.007
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The objective was to test immune protection against the formation of Toxoplasma gondii tissue cysts in rats. It has been previously shown that 50 T. gondii tissue cysts of strain Me49 are not pathogenic for CF-1 mice, whereas 1 T. gondii tissue cyst of strain M-7741, can be lethal for mice 11-13 days after subcutaneous or oral administration. In the present study, ten rats were fed T. gondii oocysts of strain Me49 and after a further 30 days they were each orally challenged with T. gondii oocysts of strain M-7741. Thirty days after this, they were euthanased and brain and muscle samples inoculated subcutaneously or orally dosed, respectively, to mice for bioassay. None of the mice died, whereas all the mice that were inoculated with brain homogenates or were fed muscle samples from four non-immunized rats that had been inoculated with T gondii oocysts of strain M-7741, died. These results encourage further research towards achieving vaccinal protection against the formation of T. gondii tissue cysts in meat animals and people. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:252 / 255
页数:4
相关论文
共 50 条
  • [21] The manipulation of rat behaviour by Toxoplasma gondii
    Berdoy, M
    Webster, JP
    MacDonald, DW
    MAMMALIA, 1995, 59 (04) : 605 - 613
  • [22] CpG-containing ODN has a limited role in the protection against Toxoplasma gondii
    Saavedra, R
    Leyva, R
    Tenorio, EP
    Haces, ML
    Rodríguez-Sosa, M
    Terrazas, LI
    Hérion, P
    PARASITE IMMUNOLOGY, 2004, 26 (02) : 67 - 73
  • [23] Toxoplasma gondii:: Immunogenicity and protection by P30 peptides in a murine model
    Siachoque, Heber
    Guzman, Fanny
    Burgos, Javier
    Patarroyo, Manuel Elkin
    Gomez Marin, Jorge Enrique
    EXPERIMENTAL PARASITOLOGY, 2006, 114 (01) : 62 - 65
  • [24] Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection
    Lee, Su-Hwa
    Kim, Ah-Ra
    Lee, Dong-Hun
    Rubino, Ilaria
    Choi, Hyo-Jick
    Quan, Fu-Shi
    PLOS ONE, 2017, 12 (04):
  • [25] THE DISTRIBUTION OF TOXOPLASMA-GONDII IN THE MUSCLES OF RATS WITH CHRONIC INFECTIONS
    JACOBS, L
    MELTON, ML
    JOURNAL OF PARASITOLOGY, 1957, 43 (05) : 41 - 42
  • [26] Study of the effect of thiosemicarbazones against Toxoplasma gondii
    Gomes, Marco Antonio G. B.
    Carreira, Gabriela M.
    Souza, Daniela P. V.
    Nogueira, Paulo Marcos R.
    de Melo, Edesio J. T.
    Maria, Edmilson J.
    COMPTES RENDUS BIOLOGIES, 2013, 336 (04) : 203 - 206
  • [27] Characterization of the Activities of Vorinostat Against Toxoplasma gondii
    Zeng, Ting
    Zhou, Chun-Xue
    Liu, Dai-Ang
    Zhao, Xiao-Yan
    An, Xu-Dian
    Liu, Zhi-Rong
    Qu, Hong-Nan
    Han, Bing
    Zhou, Huai-Yu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (02)
  • [28] Vaccines against Toxoplasma gondii: challenges and opportunities
    Jongert, Erik
    Roberts, Craig W.
    Gargano, Nicola
    Foerster-Wald, Elisabeth
    Petersen, Eskild
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2009, 104 (02): : 252 - 266
  • [29] Quinonic derivatives active against Toxoplasma gondii
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (08) : 373 - 373
  • [30] Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1
    Mishima, M
    Xuan, XN
    Shioda, A
    Omata, Y
    Fujisaki, K
    Nagasawa, H
    Mikami, T
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2001, 63 (04): : 433 - 438